Viewing Study NCT04888468


Ignite Creation Date: 2025-12-24 @ 5:30 PM
Ignite Modification Date: 2026-02-20 @ 7:25 PM
Study NCT ID: NCT04888468
Status: COMPLETED
Last Update Posted: 2022-03-18
First Post: 2021-05-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I Study of pCAR-19B in the Treatment of CD19-positive Relapsed/Refractory B-ALL in Children and Adolescents
Sponsor: Chongqing Precision Biotech Co., Ltd
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module